New Video Techniques for Monitoring Health
A fascinating set of new video techniques being developed at MIT hint at how cameras might someday intervene in crib death, help diagnose heart disease, and more.
A fascinating set of new video techniques being developed at MIT hint at how cameras might someday intervene in crib death, help diagnose heart disease, and more.
Consent and confidentiality concerns around “Big Data” in medicine should give enthusiasts for a data-rich scientific world pause. Things are more complex, and the answers so far are inadequate.
Two separate but coincidental stances toward money and OA show that when it comes to getting things done, there’s nothing quite as useful as the right incentive — even when it turns OA principles on their head.
A British explication of some nifty bar bets you can try on your friends.
Oops. Sorry.
Two funny videos of processes in scientific life which many of us can use a good laugh about. Warning — Hitler, unsurprisingly, swears like a sailor when he’s frustrated. The peer review send-up: And, if you want more, there’s the […]
3:30 p.m.: David C. notes that publishers are in an interesting quandary — they’re castigated for making a profit, yet they’re asked to make huge ongoing investments to make information more findable and usable. Publishers need to bring out the […]
The Big Deal has emerged because it had to. Where do we go from here? The answer isn’t clear.
Science begins from a simple premise, then gets really complicated. It’s good to return to the basics, courtesy of this brief primer from the legendary Richard Feynman.
The GSU case serves as a strong rebuke for publishers over fair use and copyright claims, while recognizing that some boundaries remain.
The culture of cheap has consequences, often expensive ones. Our culture of austerity economics has embraced it, to disastrous effect. Should scholarly publishing be on guard?
Registering clinical trials after enrollment has commenced may lead to the perception that medical researchers are peeking.
While BioMed Central’s responses are a mixed bag, a new finding surfaces. And this one might just beat all.
Is there a new form of conflict of interest in the world: BioMed Central’s corporate sponsorship of author fees?
The growing perception that science is built on sand demands not only some new incentives, but also an understanding that science is not always easy — or possible — to replicate.